VOYA Investment Management Portfolio holdings
AUM
$100B
1-Year Return
30.07%
This Quarter Return
+17.51%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$100B
AUM Growth
+$10.6B
(+12%)
Cap. Flow
-$9.65B
Cap. Flow
% of AUM
-9.61%
Top 10 Holdings %
Top 10 Hldgs %
26.3%
Holding
2,806
New
155
Increased
1,259
Reduced
1,080
Closed
127
Top Buys
| 1 |
Microsoft
MSFT
|
$1.03B |
| 2 |
Boston Scientific
BSX
|
$514M |
| 3 |
Caterpillar
CAT
|
$387M |
| 4 |
Cisco
CSCO
|
$366M |
| 5 |
Walt Disney
DIS
|
$363M |
Top Sells
| 1 |
Salesforce
CRM
|
$504M |
| 2 |
Palantir
PLTR
|
$326M |
| 3 |
CrowdStrike
CRWD
|
$291M |
| 4 |
Bank of America
BAC
|
$277M |
| 5 |
Cadence Design Systems
CDNS
|
$264M |
Sector Composition
| 1 | Technology | 33.81% |
| 2 | Financials | 9.82% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Healthcare | 8.11% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Rimini Street
RMNI
$416M
| $59.6K | ﹤0.01% |
15,796
| – | – |
|
2477
United States Antimony
UAMY
$561M
| $59.5K | ﹤0.01% |
+25,475
| New | +$59.5K |
|
2478
Corvus Pharmaceuticals
CRVS
$459M
| $59.1K | ﹤0.01% |
+14,774
| New | +$59.1K |
|
2479
Kaltura
KLTR
$226M
| $59K | ﹤0.01% |
29,375
+961
| +3% | +$1.93K |
|
2480
ADC Therapeutics
ADCT
$398M
| $58.7K | ﹤0.01% |
21,911
-362
| -2% | -$970 |
|
2481
Monte Rosa Therapeutics
GLUE
$305M
| $58.4K | ﹤0.01% |
12,958
+1,345
| +12% | +$6.07K |
|
2482
Aldeyra Therapeutics
ALDX
$334M
| $58.3K | ﹤0.01% |
15,226
+1,302
| +9% | +$4.99K |
|
2483
WideOpenWest
WOW
$441M
| $57.4K | ﹤0.01% |
14,143
| – | – |
|
2484
Olaplex Holdings
OLPX
$994M
| $57K | ﹤0.01% |
40,689
+2,669
| +7% | +$3.74K |
|
2485
Perspective Therapeutics
CATX
$257M
| $56.9K | ﹤0.01% |
16,546
+1,129
| +7% | +$3.88K |
|
2486
Codexis
CDXS
$218M
| $56.4K | ﹤0.01% |
23,124
+1,225
| +6% | +$2.99K |
|
2487
Cardiff Oncology
CRDF
$144M
| $56.3K | ﹤0.01% |
17,885
+1,781
| +11% | +$5.61K |
|
2488
Open Lending Corp
LPRO
$267M
| $56.3K | ﹤0.01% |
29,031
| – | – |
|
2489
Esperion Therapeutics
ESPR
$540M
| $55.7K | ﹤0.01% |
56,580
+3,814
| +7% | +$3.75K |
|
2490
Candel Therapeutics
CADL
$274M
| $55.6K | ﹤0.01% |
+10,981
| New | +$55.6K |
|
2491
3D Systems Corporation
DDD
$272M
| $55.5K | ﹤0.01% |
36,061
| – | – |
|
2492
Rocket Pharmaceuticals
RCKT
$354M
| $55.1K | ﹤0.01% |
22,508
+3,151
| +16% | +$7.72K |
|
2493
Arq
ARQ
$302M
| $55K | ﹤0.01% |
+10,249
| New | +$55K |
|
2494
Editas Medicine
EDIT
$248M
| $55K | ﹤0.01% |
25,003
+457
| +2% | +$1.01K |
|
2495
Getty Images
GETY
$772M
| $54.8K | ﹤0.01% |
32,985
+5,030
| +18% | +$8.35K |
|
2496
Sight Sciences
SGHT
$193M
| $54.7K | ﹤0.01% |
13,248
+2,831
| +27% | +$11.7K |
|
2497
Vuzix
VUZI
$188M
| $54K | ﹤0.01% |
+18,476
| New | +$54K |
|
2498
OmniAb
OABI
$246M
| $53.2K | ﹤0.01% |
30,572
+2,809
| +10% | +$4.89K |
|
2499
Verastem
VSTM
$663M
| $52.9K | ﹤0.01% |
12,758
+2,180
| +21% | +$9.05K |
|
2500
Definitive Healthcare
DH
$416M
| $52.8K | ﹤0.01% |
13,542
-1,201
| -8% | -$4.68K |
|